Success Stories: EB-1A Approved for Postdoctoral Research Fellow in New York in the Field of Biotechnology
Client’s Testimonial:
It's been a pleasure working with your team to get this I-140 approval. [...] Sure I will tell my friends who need help in their immigration process in the future.
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: September 15th, 2014
Processing Time: 28 Days (14 Days After Requesting Premium Processing)
This time we were retained by a postdoctoral research associate in biotechnology from India. Within the field of biotechnology, he focused on the highly specialized topic of the molecular mechanisms and biological processes participating in Chronic Obstructive Pulmonary Disease. His research had resulted in no less than 30 scientific peer-reviewed articles, 6 reviews, 6 book chapters, and 25 conference abstracts for presentation at national and international events. The high significance of his work is indicated in part by the excellent 808 citations his work had received at the time of filing, primarily from independent researchers around the globe. He had also reviewed 27 articles for distinguished journals in his field. An independent recommender endorsed our client’s superior ability: “[Client] designed these studies in order to determine the transcriptional regulatory processes that are changed by cigarette smoke that leads to abnormal lung inflammation. He also conducted this study to determine the role of IKKα in acetylation of histone proteins. His research also highlights the relevance of chromatin remodeling in cigarette smoke-induced lung inflammation as well as in the pathogenesis of COPD. [. . .] [Client] has shown, on a consistent basis, the ability to conduct high quality research that significantly advances our understanding of the aetiology of COPD, which is crucial in advance of finding effective treatments for this and other debilitating smoking-related chronic lung diseases.” By means of the documentation we provided, we successfully proved that our client’s continued research would substantially and prospectively benefit the United States, and qualified for classification as an Alien of Extraordinary Ability with intent to remain in the United States to continue work in the area of extraordinary ability. His case was approved in just 28 days.